ArticleHealth data science2026

Impact of China's National Volume-Based Procurement Policy on the Affordability and Utilization of Tyrosine Kinase Inhibitors for Childhood Leukemia.

Yiran Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.